Warning issued after two people suffered adverse reactions on the first day of the U.K. mass vaccination program<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Dec. 9, 2020 (HealthDay News) — People with a “significant history” of allergic reactions should not receive the new Pfizer-BioNTech COVID-19 vaccine, U.K. regulators said Tuesday.<\/p>\n
The advice was issued after two people suffered adverse reactions on the first day of the U.K. mass vaccination program, the Associated Press<\/em> reported. The regulators said they are investigating the two cases.<\/p>\n “As is common with new vaccines the [Medical and Healthcare Products Regulatory Agency (MHRA)] have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday,” Stephen Powis, national medical director of the National Health Service, said in a statement, the AP<\/em> reported. “Both are recovering well,” he added.<\/p>\n “We know from the very extensive clinical trials that this wasn’t a feature,” June Raine, head of the MHRA, told a Parliamentary committee, the AP<\/em> reported. “But If we need to strengthen our advice, now that we have had this experience with the vulnerable populations, the groups who have been selected as a priority, we get that advice to the field immediately.”<\/p>\n